Sangamo Therapeutics (SGMOQ) Free Cash Flow Growth (5y) (2015 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -24.07% |
| Sep 30, 2025 | -24.41% |
| Jun 30, 2025 | -16.16% |
| Mar 31, 2025 | -3.08% |
| Sep 30, 2024 | 15.84% |
| Jun 30, 2024 | 22.24% |
| Mar 31, 2024 | 0.78% |
| Dec 31, 2023 | 4.84% |
| Sep 30, 2023 | -6.31% |
| Jun 30, 2023 | -20.64% |
| Mar 31, 2023 | -29.82% |
| Dec 31, 2022 | -29.49% |
| Sep 30, 2022 | -28.78% |
| Jun 30, 2022 | -25.22% |
| Mar 31, 2022 | -35.47% |
| Dec 31, 2021 | -40.09% |
| Sep 30, 2021 | -27.18% |
| Jun 30, 2021 | -29.73% |
| Mar 31, 2021 | -29.99% |
| Dec 31, 2020 | 2.00% |